FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets (Medical News Today)
GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has approved Lamictal(R) ODT(TM) (lamotrigine) Orally Disintegrating Tablets. Lamictal ODT uses a novel drug-delivery formulation to provide Lamictal in a tablet that has a pleasant taste and disintegrates on the tongue.

David Epstein: FDA Reports (Sports Illustrated)
In 2008, according to documents obtained by Sports Illustrated through a Freedom of Information Act request, the FDA received a variety of adverse health event reports from consumers using supplements. The bad reactions range from a man whose heart rate was stuck at 147 beats per minute (p. 39, PDF 1) for two hours after he took a product called Fireball Liquifusion, to a woman who experienced ...

Lannett Company Receives FDA Approval For Pilocarpine HCI Tablets 7.5 Mg Strength (Medical News Today)
Lannett Company, Inc. (AMEX: LCI), a manufacturer of generic pharmaceuticals, announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its supplemental Abbreviated New Drug Application (ANDAs) for Pilocarpine HCI tablets, 7.5 mg, the generic equivalent of Salagen , marketed by Eisai Pharmaceuticals.